Evolution of potentially inappropriate medication use in nursing homes: Retrospective analysis of drug consumption data.
Fiche du document
- doi: 10.1016/j.sapharm.2020.05.032
- issn: 1551-7411
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.sapharm.2020.05.032
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32798051
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1934-8150
Ce document est lié à :
info:eu-repo/grantAgreement/SNF/Programs/167509///
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3ED58E27BD318
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Skilled nursing facilities Long-term skilled nursing facilities Skilled care facilities Nursing facilities, SkilledCiter ce document
D. Cateau et al., « Evolution of potentially inappropriate medication use in nursing homes: Retrospective analysis of drug consumption data. », Serveur académique Lausannois, ID : 10.1016/j.sapharm.2020.05.032
Métriques
Partage / Export
Résumé
The use of potentially inappropriate medication (PIMs) is frequent in nursing homes (NHs), and leads to worsened health outcomes for their residents. Numerous initiatives to curb their use have been launched. Most studies of PIMs use in NHs, however, focused on their prevalence, and provide few insights on the evolution of their use. The objective of this analysis is to measure the evolution of PIMs use in the nursing NHs of western Switzerland taking part in an integrated pharmacy service (IPS). Drug consumption data from 166 NHs were collected for 2014 to 2018, through the monitoring of the IPS. These data were cross-referenced with validated PIMs lists (Beers' list and Norwegian General Practice-Nursing Home, NORGEP-NH) to compute the number of potentially inappropriate defined daily doses per average resident (DDD/res) in each NH. Linear mixed-effects models were used to assess the evolution of PIMs use over time, following the NORGEP-NH classification of PIMs and the drug classes involved. In 2018, the number of DDD/res was 7.3 (SD 1.9); of those, 2.2 (SD 0.8) were potentially inappropriate. Psycholeptics, psychoanaleptics and antihypertenseives were the most-used PIMs. Between 2014 and 2018, the number of potentially inappropriate DDD/res decreased by 0.03 per year (CI 95 [-0.05; -0.01]). This study complements others that focused on the prevalence of PIMs use in NHs. The statistically significant reduction in the use of PIMs is an encouraging sign, but is probably not clinically meaningful for NH residents. With the growing concerns of the potential harms of these drugs, more specific interventions and implementation strategies need to be developed to help clinicians further reduce their use in NHs.